The Share Centre also reports that sector specific funds have made their way into the of top 10 traded funds, one for the first time since 2015. The company says that investors appear to want managers who have “proven track records” of managing money through various economic conditions. The popular Woodford Equity Income fund tops the list.
The Share Centre’s top 10 traded funds in August 2016 were:
1 CF Woodford Equity Income fund
2 Fundsmith Equity fund
3 Legg Mason Japan Equity fund
4 Jupiter India fund
5 Lindsell Train Global Equity fund
6 Newton Global Income fund
7 Polar Capital Healthcare Opportunities fund
8 Stewart Investors Asia Pacific Leaders fund
9 Rathbone Global Opportunities fund
10 AXA Framlington Biotech fund
Andy Parsons, head of investment research at The Share Centre, said: “Customers at The Share Centre continue to want to benefit from the widely trusted Neil Woodford as the CF Woodford Equity Income fund tops the top traded fund list once more.
“The data, which is based on the number of deals completed by our customers, indicates that investors stuck with the reliable and trusted Neil Woodford post Brexit and interestingly, this is the only fund which has a predominant UK focus that features this month. The fund offers a portfolio which comprises not only a core nucleus of blue chip companies, but a number of exciting young vibrant businesses just starting out.
“In second position is the Fundsmith Equity fund which is beginning to feature prominently in either second or third position behind Woodford. The portfolio adopts a high conviction, concentrated approach, with the vast majority of underlying investments being household names from a global perspective.
“In third and fourth positions are two funds that have a very specific geographic focus, namely the Legg Mason Japan Equity fund and Jupiter India fund. Halfway through the table are two funds with an alternative global approach for investors in the Lindsell Train Global Equity fund and the Newton Global Income fund in fifth and sixth positions respectively.
He added that in seventh place was the Polar Capital Healthcare Opportunities fund, a popular choice with our investors in 2015 but the first time it has appeared in 2016.
Also in the top 10 was Stewart Investors Asia Pacific Leaders fund, the Rathbone Global Opportunities fund and the AXA Framlington Biotech fund, underlying the variety of funds investors have chosen since Brexit.